AUPH

Huizinga Robert Bindert

Known title: EVP of ResearchCIK: 0001837648

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 7, 2026

AUPH Appears in Report on Activist Investor Activity. Aurinia Pharmaceuticals was mentioned among stocks drawing attention from activist investors, according to recent financial news coverage. No specific activist involvement details or corporate action plans were detailed in the report. The stock is currently trading between its 52-week range extremes, with analysts maintaining price targets notably above current levels.

this person other insiders at AUPH

Transaction History

AUPH▲ Buy$0
AUPH▼ Sell$58K
AUPH▲ Buy$304K
AUPH▼ Sell$3.9M
AUPH▲ Buy$42K
AUPH▲ Buy$36K
AUPH▼ Sell$653K
AUPH▼ Sell$127K
AUPH▼ Sell$489K
AUPH▼ Sell$99K
AUPH▼ Sell$99K
AUPH▼ Sell$92K

We use analytics to understand how market-wall is used. No personal data is sold.